Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 8—August 2004

Syphilis in the HIV Era

Sigall Kassutto*Comments to Author  and John P. Doweiko*
Author affiliations: *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Main Article


Selected laboratory results 1 month after therapy for neurosyphilis in HIV-positive patient with neurosyphilisa

Laboratory test Result
Complete blood count
Leukocytes 5,700/μL
Hematocrit 36%
Platelets 295,000/μL
Electrolytes and renal function tests Within normal limits
Liver function tests Within normal limits
Cerebrospinal fluid evaluation
Leukocytes 8 cells/μL
Differential 100% lymphocytes
Erythrocytes 9 cells/μL
Protein 33 mg/dL
Glucose 78 mg/dL
CSF-VDRL negative
HIV-1 testing
ELISA + WB positive
CD4 count 899 cells/μL
Viral load (RT-PCR) 878 copies/mL
Rapid plasma reagin testing
Baseline 1:128
1 month posttreatment 1:32
3 months posttreatment Nonreactive

aCSF-VDRL, cerebrospinal fluid venereal disease research laboratory test; ELISA, enzyme-linked immunosorbent assay; WB, Western blot; RT-PCR, reverse transcription–polymerase chain reaction.

Main Article

Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.